Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Standard BioTools Inc | Eli Casdin D. | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 11,246,525 | 11,246,525 (15%) | 15% | - | Common Stock | |
| Standard BioTools Inc | Eli D. Casdin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 7,548,000 | 7,548,000 (10%) | 10% | - | Common Stock | |
| Standard BioTools Inc | Casdin D. Eli | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 4,824,802 | 4,824,802 | - | - | Warrant to purchase common stock (Right to buy) | |
| Standard BioTools Inc | Casdin Eli D. | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 2,744,219 | 2,744,219 (3%) | 3% | - | Common Stock | |
| Sinclair Inc (Class A) | David D. Smith | Director, Executive Chairman, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 05 Jan 2024 | 1,500,000 | 2,411,072 | - | - | Class B Common Stock | |
| Sinclair Inc (Class A) | David D. Smith | Director, Executive Chairman, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 05 Jan 2024 | 1,500,000 | 3,911,072 | - | - | Class B Common Stock | |
| Sinclair Inc (Class A) | David D. Smith | Director, Executive Chairman, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 05 Jan 2024 | 1,500,000 | 5,411,072 | - | - | Class B Common Stock | |
| Sinclair Inc (Class A) | David D. Smith | Director, Executive Chairman, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 05 Jan 2024 | 1,500,000 | 6,911,072 | - | - | Class B Common Stock | |
| TG Therapeutics Inc | S. Weiss Michael | CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 1,001,908 | 13,074,929 (11%) | 0% | 0 | Common Stock | |
| Sinclair Inc (Class A) | David D. Smith | Director, Executive Chairman, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jan 2024 | 1,000,000 | 4,911,072 | - | - | Class B Common Stock | |
| Sinclair Inc (Class A) | David D. Smith | Director, Executive Chairman, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jan 2024 | 1,000,000 | 1,000,000 | - | - | Class B Common Stock | |
| Sinclair Inc (Class A) | David D. Smith | Director, Executive Chairman, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jan 2024 | 1,000,000 | 3,911,072 | - | - | Class B Common Stock | |
| Sinclair Inc (Class A) | David D. Smith | Director, Executive Chairman, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jan 2024 | 1,000,000 | 1,000,000 | - | - | Class B Common Stock | |
| Sinclair Inc (Class A) | David D. Smith | Director, Executive Chairman, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jan 2024 | 1,000,000 | 2,911,072 | - | - | Class B Common Stock | |
| Sinclair Inc (Class A) | David D. Smith | Director, Executive Chairman, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jan 2024 | 1,000,000 | 1,000,000 | - | - | Class B Common Stock | |
| Sinclair Inc (Class A) | David D. Smith | Director, Executive Chairman, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jan 2024 | 1,000,000 | 5,911,072 | - | - | Class B Common Stock | |
| Sinclair Inc (Class A) | David D. Smith | Director, Executive Chairman, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jan 2024 | 1,000,000 | 1,000,000 | - | - | Class B Common Stock | |
| Standard BioTools Inc | M. Cox Troy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 982,811 | 982,811 | - | - | Stock Option (Right to buy) | |
| Agilon Health Inc | Ronald Williams A. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.00 per share. | 05 Jan 2024 | 950,000 | 3,414,414 | - | 1 | 950,000 | Common Stock |
| Agilon Health Inc | A. Williams Ronald | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 950,000 | 0 | - | - | Options (Rights to Buy) | |
| ATAI Life Sciences N.V. | Christian Angermayer | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 642,000 | 642,000 | - | - | Stock Option | |
| Atyr Pharma Inc | Sanjay Shukla S. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 600,000 | 600,000 | - | - | Employee Stock Option (right to buy) | |
| LXP Industrial Trust | Wilson T. Eglin | Director, Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 9.61 per share. | 05 Jan 2024 | 424,558 | 3,230,481 (1%) | 0% | 9.6 | 4,080,002 | Common Shares |
| Opko Health Inc | A. Elias Zerhouni | Director, Vice Chairman and President | Purchase of securities on an exchange or from another person at price $ 0.94 per share. | 05 Jan 2024 | 400,000 | 20,327,814 (3%) | 0% | 0.9 | 376,000 | Common Stock |
| Presidio Property Trust Inc (Class A) | Heilbron Jack K. | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 1.20 per share. | 05 Jan 2024 | 360,000 | 710,156 | - | 1.2 | 432,000 | Common Stock - Series A |
| Zymeworks BC Inc | Kenneth Galbraith | Director, Chair & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| Day One Biopharma Inc | Bender Jeremy | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 286,000 | 286,000 | - | - | Stock Option (right to buy Common Stock) | |
| Vera Therapeutics Inc (Class A) | D. Turner William | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 275,000 | 275,000 | - | - | Stock Option (right to buy) | |
| Lexeo Therapeutics Inc | Richard Nolan Townsend | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 262,500 | 262,500 | - | - | Stock Option (Right to Buy) | |
| Presidio Property Trust Inc (Class A) | Gary Katz M. | SVP, Asset Management | Grant, award, or other acquisition of securities at price $ 1.20 per share. | 05 Jan 2024 | 250,945 | 675,011 | - | 1.2 | 301,134 | Common Stock - Series A |
| Hoth Therapeutics Inc | Knie Robb | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 225,000 | 225,000 | - | - | Options | |
| Standard BioTools Inc | Michael Egholm | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 212,126 | 634,156 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Kathy Hibbs L. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 205,794 | 205,794 | - | - | Stock Option (Right to buy) | |
| Zymeworks BC Inc | Galbraith Kenneth | Director, Chair & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 200,000 | 200,000 | - | - | Restricted Stock Unit | |
| Standard BioTools Inc | Michael Egholm | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 196,512 | 393,025 | - | - | Restricted Stock Units | |
| Standard BioTools Inc | Michael Egholm | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 196,512 | 422,030 (0%) | 0% | 0 | Common Stock | |
| TimkenSteel Corp | Michael Williams S. | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.04 per share. | 05 Jan 2024 | 192,322 | 370,278 (0%) | 0% | 22.0 | 4,238,777 | Common Shares |
| Standard BioTools Inc | Troy M. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 190,365 | 190,365 | - | - | Stock Option (Right to buy) | |
| Day One Biopharma Inc | Jeremy Bender | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 187,000 | 187,000 | - | - | Restricted Stock Units | |
| Standard BioTools Inc | M. Cox Troy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 184,999 | 184,999 | - | - | Warrant to purchase Common Stock (Right to buy) | |
| EyePoint Pharma Inc | Duker S. Jay | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 180,000 | 180,000 | - | - | Stock Option (Right to Buy) | |
| Day One Biopharma Inc | N. Charles York | COO, CFO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 162,000 | 162,000 | - | - | Stock Option (right to buy Common Stock) | |
| Nuvalent Inc (Class A) | R. James Porter | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 161,100 | 161,100 | - | - | Stock Option (Right to Buy) | |
| Sterling infra Inc | Cutillo Joseph A. | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 160,000 | 160,000 | - | - | Performance-Based Restricted Stock Units | |
| LXP Industrial Trust | Bonventre S. Joseph | EVP, COO, Gen.Counsel & Sec | Grant, award, or other acquisition of securities at price $ 9.61 per share. | 05 Jan 2024 | 156,088 | 823,734 (0%) | 0% | 9.6 | 1,500,006 | Common Shares |
| Agilon Health Inc | A. Williams Ronald | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.00 per share. | 05 Jan 2024 | 150,000 | 3,564,414 | - | 3 | 450,000 | Common Stock |
| Agilon Health Inc | Ronald A. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 150,000 | 0 | - | - | Options (Rights to Buy) | |
| Atyr Pharma Inc | M. Jill Broadfoot | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 150,000 | 150,000 | - | - | Employee Stock Option (right to buy) | |
| Atyr Pharma Inc | E. Denyes Nancy | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 150,000 | 150,000 | - | - | Employee Stock Option (right to buy) | |
| Scienture Holdings Inc | Prashant Patel | Director, Interim CFO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 150,000 | 150,000 | - | 0 | Common stock | |
| Scienture Holdings Inc | K. Surendra Ajjarapu | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 150,000 | 150,000 | - | 0 | Common stock | |
| Day One Biopharma Inc | Blackman Samuel | Head of Research and Developme | 05 Jan 2024 | 148,000 | 148,000 | - | - | Stock Option (right to buy Common Stock) | ||
| Lexeo Therapeutics Inc | Jenny R. Robertson | Chief Legal and Admin Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 142,500 | 142,500 | - | - | Stock Option (Right to Buy) | |
| LXP Industrial Trust | T. Eglin Wilson | Director, Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 9.61 per share. | 05 Jan 2024 | 141,520 | 2,805,923 (1%) | 0% | 9.6 | 1,360,007 | Common Shares |
| LXP Industrial Trust | P. Brendan Mullinix | EVP & Chief Investment Officer | Grant, award, or other acquisition of securities at price $ 9.61 per share. | 05 Jan 2024 | 131,114 | 668,536 (0%) | 0% | 9.6 | 1,260,006 | Common Shares |
| Nuvalent Inc (Class A) | James Porter R. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 112,800 | 188,113 | - | 0 | Class A Common Stock | |
| LXP Industrial Trust | Beth Boulerice | EVP, CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 9.61 per share. | 05 Jan 2024 | 112,383 | 344,680 (0%) | 0% | 9.6 | 1,080,001 | Common Shares |
| Day One Biopharma Inc | York Charles N. | COO, CFO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 106,000 | 106,000 | - | - | Restricted Stock Units | |
| SI-BONE Inc | Francis Laura A. | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 100,653 | 439,410 (1%) | 0% | 0 | Common Stock | |
| SI-BONE Inc | Laura A. Francis | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 100,653 | 540,063 (2%) | 0% | 0 | Common Stock | |
| Hoth Therapeutics Inc | Graig Springer | Director | 05 Jan 2024 | 100,000 | 100,000 | - | - | Options | ||
| Opko Health Inc | Elias Zerhouni A. | Director, Vice Chairman and President | Purchase of securities on an exchange or from another person at price $ 0.93 per share. | 05 Jan 2024 | 100,000 | 19,927,814 (2%) | 0% | 0.9 | 93,000 | Common Stock |
| 22nd Century Grp Inc | Andrew Arno | Director | Purchase of securities on an exchange or from another person at price $ 0.17 per share. | 05 Jan 2024 | 100,000 | 100,000 (0%) | 0% | 0.2 | 17,490 | Common Stock |
| MDU Resources Grp Inc | Goodin L. David | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Jan 2024 | 99,649 | 642,907 (0%) | 0% | 0 | Common Stock | |
| Day One Biopharma Inc | Blackman Samuel | Head of Research and Developme | 05 Jan 2024 | 97,000 | 97,000 | - | - | Restricted Stock Units | ||
| Sabra Healthcare REIT Inc | K. Richard Matros | Director, Chair, CEO and President | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jan 2024 | 93,042 | 499,903 (0%) | 0% | 0 | Common Stock | |
| Sabra Healthcare REIT Inc | Matros K. Richard | Director, Chair, CEO and President | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jan 2024 | 93,042 | 1,472,841 (0%) | 0% | 0 | Common Stock | |
| Artelo Biosciences Inc | D. Gorgas Gregory | Director, Pres, CEO, CFO, Treas & Secr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 92,000 | 92,000 | - | - | Stock Option (right to buy) | |
| EyePoint Pharma Inc | O. George Elston | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 90,000 | 90,000 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharma Inc | S. Duker Jay | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 90,000 | 90,000 | - | - | Restricted Stock Units | |
| Zymeworks BC Inc | Moore Andrew Paul | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 90,000 | 90,000 | - | - | Stock Option (Right to Buy) | |
| Zymeworks BC Inc | Jeffrey T.L. Smith | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 90,000 | 90,000 | - | - | Stock Option (Right to Buy) | |
| Day One Biopharma Inc | Adam Dubow | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 90,000 | 90,000 | - | - | Stock Option (right to buy Common Stock) | |
| LXP Industrial Trust | James Dudley | EVP & Director of Asset Mgmt. | Grant, award, or other acquisition of securities at price $ 9.61 per share. | 05 Jan 2024 | 87,409 | 348,379 (0%) | 0% | 9.6 | 840,000 | Common Shares |
| Standard BioTools Inc | Troy M. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 87,057 | 87,057 (0%) | 0% | - | Common Stock | |
| Standard BioTools Inc | Cox Troy M. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 79,412 | 166,469 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Hibbs Kathy L. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 79,412 | 79,412 (0%) | 0% | 0 | Common Stock | |
| EyePoint Pharma Inc | S. Nancy Lurker | Director, Executive Vice Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 77,000 | 77,000 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharma Inc | Lurker Nancy S. | Director, Executive Vice Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 75,133 | 150,267 | - | - | Restricted Stock Units | |
| EyePoint Pharma Inc | Nancy Lurker S. | Director, Executive Vice Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 75,133 | 193,484 (0%) | 0% | 0 | Common Stock | |
| Research Soln Inc | Victor Derycz Peter | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.70 per share. | 05 Jan 2024 | 69,676 | 3,101,208 | - | 2.7 | 188,125 | Common Stock |
| APA | J. John Christmann | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 67,524 | 182,912 | - | - | Restricted Stock / Units | |
| Butterfly Network Inc (Class A) | Getz Heather | EVP, CFO & COO | 05 Jan 2024 | 66,142 | 1,517,236 | - | 1.0 | 67,465 | Class A Common Stock | |
| Sabra Healthcare REIT Inc | Matros K. Richard | Director, Chair, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.64 per share. | 05 Jan 2024 | 66,016 | 592,945 (0%) | 0% | 13.6 | 900,458 | Common Stock |
| Workday (Class A) | Duffield A. David | Ten Percent Owner | 05 Jan 2024 | 65,839 | 44,066,493 | - | - | Class B Common Stock | ||
| Workday (Class A) | David Duffield A. | Ten Percent Owner | 05 Jan 2024 | 65,839 | 168,836 (0%) | 0% | 0 | Class A Common Stock | ||
| Thryv Holdings Inc | Walsh Joseph A. | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 65,825 | 496,814 | - | 0 | Common Shares | |
| Workday (Class A) | Duffield David A. | Ten Percent Owner | 05 Jan 2024 | 65,524 | 44,132,332 | - | - | Class B Common Stock | ||
| Workday (Class A) | Duffield A. David | Ten Percent Owner | 05 Jan 2024 | 65,524 | 168,521 (0%) | 0% | 0 | Class A Common Stock | ||
| Mission Produce Inc | Stephen J. Barnard | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 61,792 | 208,437 | - | 0 | COMMON STOCK | |
| Zymeworks BC Inc | Moore Paul Andrew | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 60,000 | 60,000 | - | - | Restricted Stock Unit | |
| Zymeworks BC Inc | Jeffrey T.L. Smith | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 60,000 | 60,000 | - | - | Restricted Stock Unit | |
| Day One Biopharma Inc | Adam Dubow | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 59,000 | 59,000 | - | - | Restricted Stock Units | |
| Thryv Holdings Inc | D. Paul Rouse | CFO, Executive VP & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 54,854 | 154,111 | - | 0 | Common Shares | |
| Cloudflare Inc (Class A) | Prince Matthew | Director, CEO & Chair of the Board, Ten Percent Owner | 05 Jan 2024 | 52,384 | 11,989,162 | - | - | Class B Common Stock | ||
| Cloudflare Inc (Class A) | Matthew Prince | Director, CEO & Chair of the Board, Ten Percent Owner | 05 Jan 2024 | 52,384 | 52,384 (0%) | 0% | - | Class A Common Stock | ||
| Cloudflare Inc (Class A) | Prince Matthew | Director, CEO & Chair of the Board, Ten Percent Owner | 05 Jan 2024 | 52,384 | 11,936,778 | - | - | Class B Common Stock | ||
| Cloudflare Inc (Class A) | Prince Matthew | Director, CEO & Chair of the Board, Ten Percent Owner | 05 Jan 2024 | 52,384 | 52,384 (0%) | 0% | - | Class A Common Stock | ||
| LXP Industrial Trust | Bonventre Joseph S. | EVP, COO, Gen.Counsel & Sec | Grant, award, or other acquisition of securities at price $ 9.61 per share. | 05 Jan 2024 | 52,030 | 667,646 (0%) | 0% | 9.6 | 500,008 | Common Shares |
| Amplify Energy Corp | Willsher Martyn | Director, PRESIDENT, CEO | 05 Jan 2024 | 51,892 | 172,330 (0%) | 0% | - | Common Stock, par value $0.01 per share | ||
| Standard BioTools Inc | Troy Cox M. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 51,842 | 51,842 | - | - | Stock Option (Right to buy) | |
| Standard BioTools Inc | D. Eli Casdin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 51,842 | 51,842 | - | - | Stock Option (Right to buy) | |
| SI-BONE Inc | Recupero J. Anthony | President, Commercial Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 51,007 | 249,910 (0%) | 0% | 0 | Common Stock | |
| SI-BONE Inc | Anshul Maheshwari | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 51,007 | 198,275 (0%) | 0% | 0 | Common Stock | |
| Fortress Biotech Inc | Rosenwald Lindsay A. | Director, President, CEO & Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.38 per share. | 05 Jan 2024 | 50,000 | 2,863,905 (4%) | 0% | 2.4 | 118,770 | COMMON STOCK, PAR VALUE $0.001 |
| Zymeworks BC Inc | Astle Christopher | SVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Zymeworks BC Inc | Galbraith Kenneth | Director, Chair & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 47,666 | 47,666 (0%) | 0% | 0 | Common Stock | |
| Zymeworks BC Inc | Galbraith Kenneth | Director, Chair & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 47,666 | 95,334 | - | - | Restricted Stock Unit | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 47,500 | 47,500 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Miller Deborah | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 47,500 | 47,500 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Turner D. Christopher | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 47,500 | 47,500 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Noci Darlene | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 47,500 | 47,500 | - | - | Stock Option (Right to Buy) | |
| MDU Resources Grp Inc | L. Goodin David | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.85 per share. | 05 Jan 2024 | 47,350 | 595,557 (0%) | 0% | 20.9 | 987,248 | Common Stock |
| Vroom Inc | H. Shortt Thomas | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.54 per share. | 05 Jan 2024 | 47,030 | 3,172,839 | - | 0.5 | 25,283 | Common Stock |
| Standard BioTools Inc | Casdin D. Eli | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 46,514 | 46,514 | - | - | Stock Option (Right to buy) | |
| APA | John Christmann J. | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 45,958 | 583,505 (0%) | 0% | 0 | Common Stock | |
| APA | Christmann J. John | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 45,958 | 115,388 | - | - | Restricted Stock / Units | |
| Citizens Inc (Class A) | Sheryl Kinlaw | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 45,518 | 45,518 | - | - | Restricted Stock Units | |
| APA | Christmann J. John | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 45,016 | 227,928 | - | - | Restricted Stock / Units | |
| EyePoint Pharma Inc | Elston George O. | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 45,000 | 45,000 | - | - | Restricted Stock Units | |
| Thryv Holdings Inc | Freeman Grant | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 43,883 | 94,184 | - | 0 | Common Stock | |
| Orthofix Medical Inc | A. Kimberley Elting | President, Global Orthopedics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 43,867 | 43,867 | - | - | Employee Stock Option (Right to Buy) | |
| Lexeo Therapeutics Inc | Richard Nolan Townsend | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 43,750 | 170,695 | - | 0 | Common Stock | |
| LXP Industrial Trust | P. Brendan Mullinix | EVP & Chief Investment Officer | Grant, award, or other acquisition of securities at price $ 9.61 per share. | 05 Jan 2024 | 43,710 | 537,422 (0%) | 0% | 9.6 | 420,053 | Common Shares |
| Graco Inc | Sheahan W. Mark | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.93 per share. | 05 Jan 2024 | 43,080 | 106,065 (0%) | 0% | 24.9 | 1,074,127 | Common Stock |
| Workday (Class A) | A. David Duffield | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 265.60 per share. | 05 Jan 2024 | 42,523 | 114,945 (0%) | 0% | 265.6 | 11,294,028 | Class A Common Stock |
| EyePoint Pharma Inc | Jones David Scott | SVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 42,000 | 42,000 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharma Inc | Pine C. Michael | Chief Corp Dev.&Strat. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 42,000 | 42,000 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharma Inc | Dario A. Paggiarino | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 42,000 | 42,000 | - | - | Stock Option (Right to Buy) | |
| Cloudflare Inc (Class A) | Matthew Prince | Director, CEO & Chair of the Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 76.67 per share. | 05 Jan 2024 | 41,870 | 10,514 (0%) | 0% | 76.7 | 3,210,215 | Class A Common Stock |
| Cloudflare Inc (Class A) | Prince Matthew | Director, CEO & Chair of the Board, Ten Percent Owner | 05 Jan 2024 | 41,661 | 52,384 (0%) | 0% | - | Class A Common Stock | ||
| Cloudflare Inc (Class A) | Matthew Prince | Director, CEO & Chair of the Board, Ten Percent Owner | 05 Jan 2024 | 41,661 | 12,041,546 | - | - | Class B Common Stock | ||
| OFG Bancorp | Fernandez Rafael Jose | Director, CEO & Vice Chairperson BOD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 40,442 | 83,909 | - | - | Restricted Units | |
| APA | Stephen Riney J. | Executive Vice Pres & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 38,422 | 93,171 | - | - | Restricted Stock / Units | |
| Thryv Holdings Inc | Bolger Lesley | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 38,398 | 84,178 | - | 0 | Common Stock | |
| Thryv Holdings Inc | Gordon Henry | Chief Strategy Officer and EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 38,398 | 90,602 | - | 0 | Common Shares | |
| Thryv Holdings Inc | F. John Wholey | Executive VP of Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 38,398 | 184,791 | - | 0 | Common Stock | |
| Thryv Holdings Inc | James McCusker | Chief Revenue Officer and EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 38,398 | 96,707 | - | 0 | Common Shares | |
| Thryv Holdings Inc | John F. Wholey | Executive VP of Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 38,398 | 183,476 | - | 0 | Common Stock | |
| EyePoint Pharma Inc | Lurker Nancy S. | Director, Executive Vice Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 38,000 | 38,000 | - | - | Restricted Stock Units | |
| LXP Industrial Trust | Boulerice Beth | EVP, CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 9.61 per share. | 05 Jan 2024 | 37,470 | 232,297 (0%) | 0% | 9.6 | 360,087 | Common Shares |
| SEMrush Holdings Inc (Class A) | Levin Eugenie | President | 05 Jan 2024 | 35,613 | 342,450 | - | 0 | Class A Common Stock | ||
| SEMrush Holdings Inc (Class A) | Eugenie Levin | President | 05 Jan 2024 | 35,613 | 1,210,800 | - | - | Class B Common Stock | ||
| SEMrush Holdings Inc (Class A) | Levin Eugenie | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 35,613 | 298,191 | - | - | Employee Stock Option (Right to Buy) | |
| SEMrush Holdings Inc (Class A) | Levin Eugenie | President | Sale of securities on an exchange or to another person at price $ 12.52 per share. | 05 Jan 2024 | 35,613 | 271,285 | - | 12.5 | 445,875 | Class A Common Stock |
| SEMrush Holdings Inc (Class A) | Eugenie Levin | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 35,613 | 1,246,413 | - | - | Class B Common Stock | |
| Butterfly Network Inc (Class A) | G. Andrei Stoica | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 1.02 per share. | 05 Jan 2024 | 35,612 | 978,286 | - | 1.0 | 36,324 | Class A Common Stock |
| SEMrush Holdings Inc (Class A) | Eugenie Levin | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 35,552 | 99,572 | - | - | Employee Stock Option (Right to Buy) | |
| SEMrush Holdings Inc (Class A) | Levin Eugenie | President | 05 Jan 2024 | 35,552 | 1,210,800 | - | - | Class B Common Stock | ||
| SEMrush Holdings Inc (Class A) | Eugenie Levin | President | 05 Jan 2024 | 35,552 | 306,837 | - | 0 | Class A Common Stock | ||
| SEMrush Holdings Inc (Class A) | Eugenie Levin | President | Sale of securities on an exchange or to another person at price $ 12.51 per share. | 05 Jan 2024 | 35,552 | 306,898 | - | 12.5 | 444,756 | Class A Common Stock |
| SEMrush Holdings Inc (Class A) | Levin Eugenie | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 35,552 | 1,246,352 | - | - | Class B Common Stock | |
| Mission Produce Inc | E. Bryan Giles | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 35,016 | 130,628 | - | 0 | COMMON STOCK | |
| CSP Inc | Dellovo Victor | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 35,000 | 398,305 (9%) | 0% | 0 | Common Stock | |
| Nuvalent Inc (Class A) | D. Turner Christopher | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 33,300 | 47,813 | - | 0 | Class A Common Stock | |
| Nuvalent Inc (Class A) | Noci Darlene | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 33,300 | 33,300 | - | 0 | Class A Common Stock | |
| Nuvalent Inc (Class A) | Miller Deborah | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 33,300 | 33,300 | - | 0 | Class A Common Stock | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 33,300 | 33,300 | - | 0 | Class A Common Stock | |
| Opko Health Inc | A. Elias Zerhouni | Director, Vice Chairman and President | Purchase of securities on an exchange or from another person at price $ 0.91 per share. | 05 Jan 2024 | 33,300 | 19,827,814 (2%) | 0% | 0.9 | 30,303 | Common Stock |
| Citizens Inc (Class A) | Sheryl Kinlaw | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 32,710 | 32,710 | - | - | Restricted Stock Units | |
| Standard BioTools Inc | M. Troy Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 31,635 | 198,104 (0%) | 0% | - | Common Stock | |
| SEMrush Holdings Inc (Class A) | Eugenie Levin | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 31,406 | 266,785 | - | - | Employee Stock Option (Right to Buy) | |
| SEMrush Holdings Inc (Class A) | Levin Eugenie | President | 05 Jan 2024 | 31,406 | 1,210,800 | - | - | Class B Common Stock | ||
| SEMrush Holdings Inc (Class A) | Eugenie Levin | President | 05 Jan 2024 | 31,406 | 312,206 | - | 0 | Class A Common Stock | ||
| SEMrush Holdings Inc (Class A) | Levin Eugenie | President | Sale of securities on an exchange or to another person at price $ 12.47 per share. | 05 Jan 2024 | 31,406 | 271,285 | - | 12.5 | 391,633 | Class A Common Stock |
| SEMrush Holdings Inc (Class A) | Eugenie Levin | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 31,406 | 1,242,206 | - | - | Class B Common Stock | |
| Amplify Energy Corp | Willis M. Eric | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 31,134 | 148,871 (0%) | 0% | - | Common Stock, par value $0.01 per share | |
| Amplify Energy Corp | Willsher Martyn | Director, PRESIDENT, CEO | 05 Jan 2024 | 31,073 | 116,213 | - | - | Performance Stock Units | ||
| Exelixis Inc | Mary Beckerle C. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 30,848 | 30,848 | - | - | Option (right to buy) | |
| Exelixis Inc | Eckhardt Gail Sue | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 30,848 | 30,848 | - | - | Option (right to buy) | |
| Ecovyst Inc | J. Bitting Kurt | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.46 per share. | 05 Jan 2024 | 30,705 | 385,013 (0%) | 0% | 9.5 | 290,469 | Common Stock |
| APA | John J. Christmann | Director, CEO and President | Sale or transfer of securities back to the company at price $ 34.34 per share. | 05 Jan 2024 | 30,639 | 537,547 (0%) | 0% | 34.3 | 1,052,143 | Common Stock |
| APA | J. Christmann John | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 30,639 | 161,346 | - | - | Restricted Stock / Units | |
| APA | Christmann John J. | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 30,639 | 568,186 (0%) | 0% | - | Common Stock | |
| Workday (Class A) | A. Duffield David | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 272.34 per share. | 05 Jan 2024 | 30,343 | 129,047 (0%) | 0% | 272.3 | 8,263,552 | Class A Common Stock |
| Cloudflare Inc (Class A) | Matthew Prince | Director, CEO & Chair of the Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 81.26 per share. | 05 Jan 2024 | 30,278 | 0 (0%) | 0% | 81.3 | 2,460,360 | Class A Common Stock |
| Zymeworks BC Inc | Christopher Astle | SVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 30,000 | 30,000 | - | - | Restricted Stock Unit | |
| Edwards Lifesciences | Michael Mussallem A. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 29,350 | 117,400 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences | Michael A. Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 05 Jan 2024 | 29,350 | 33,835 (0%) | 0% | 36.8 | 1,078,613 | Common Stock |
| V2X Inc | Beard William Wayne | SVP, Aerospace Solutions | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 29,315 | 64,469 (0%) | 0% | - | V2X, Inc. Common Stock | |
| V2X Inc | William Wayne Beard | SVP, Aerospace Solutions | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 29,315 | 29,314 | - | - | Restricted Stock Units | |
| LXP Industrial Trust | Dudley James | EVP & Director of Asset Mgmt. | Grant, award, or other acquisition of securities at price $ 9.61 per share. | 05 Jan 2024 | 29,140 | 260,970 (0%) | 0% | 9.6 | 280,035 | Common Shares |
| Graco Inc | Sheahan W. Mark | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.37 per share. | 05 Jan 2024 | 27,845 | 78,220 (0%) | 0% | 83.4 | 2,321,438 | Common Stock |
| Rafael Holdings Inc (Class B) | Weiss J. Michael | Director | Grant, award, or other acquisition of securities at price $ 1.81 per share. | 05 Jan 2024 | 27,655 | 74,950 (0%) | 0% | 1.8 | 50,056 | Class B Common Stock, par value $.01 per share |
| Rafael Holdings Inc (Class B) | M. Stephen Greenberg | Director | 05 Jan 2024 | 27,655 | 74,950 (0%) | 0% | 1.8 | 50,056 | Class B Common Stock, par value $.01 per share | |
| Rafael Holdings Inc (Class B) | Mccamish Mark A. | Director | Grant, award, or other acquisition of securities at price $ 1.81 per share. | 05 Jan 2024 | 27,655 | 60,241 (0%) | 0% | 1.8 | 50,056 | Class B Common Stock, par value $.01 per share |
| Edwards Lifesciences | Mussallem Michael A. | Director | Sale of securities on an exchange or to another person at price $ 72.94 per share. | 05 Jan 2024 | 26,850 | 4,485 (0%) | 0% | 72.9 | 1,958,439 | Common Stock |
| Workday (Class A) | David A. Duffield | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 272.95 per share. | 05 Jan 2024 | 26,050 | 102,997 (0%) | 0% | 272.9 | 7,110,241 | Class A Common Stock |
| Mission Produce Inc | Joanne C. Wu | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 25,747 | 63,873 | - | 0 | COMMON STOCK | |
| APA | Stephen Riney J. | Executive Vice Pres & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 25,615 | 118,786 | - | - | Restricted Stock / Units | |
| Agios Pharma Inc | Goff Brian | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 25,527 | 52,119 (0%) | 0% | 0 | Common stock | |
| Agios Pharma Inc | Brian Goff | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 25,527 | 119,128 | - | - | Performance share units | |
| EyePoint Pharma Inc | Wendy F. DiCicco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 25,014 | 25,014 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharma Inc | P. Adamis Anthony | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 25,014 | 25,014 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharma Inc | Karen Zaderej | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 25,014 | 25,014 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharma Inc | Stuart Duty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 25,014 | 25,014 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharma Inc | Landis B. John | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 25,014 | 25,014 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharma Inc | R. David Guyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 25,014 | 25,014 | - | - | Stock Option (Right to Buy) | |
| Hoth Therapeutics Inc | D. Wayne Linsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 25,000 | 25,000 | - | - | Options | |
| Hoth Therapeutics Inc | Pavell Jeff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 25,000 | 25,000 | - | - | Options | |
| Hoth Therapeutics Inc | Sarnoff David B. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 25,000 | 25,000 | - | - | Options | |
| Hoth Therapeutics Inc | Graig Springer | Director | 05 Jan 2024 | 25,000 | 25,000 | - | - | Options | ||
| Opko Health Inc | John A. Paganelli | Director | Purchase of securities on an exchange or from another person at price $ 0.88 per share. | 05 Jan 2024 | 25,000 | 384,340 (0%) | 0% | 0.9 | 22,080 | Common Stock |
| Amplify Energy Corp | Lopez Anthony William | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 24,018 | 87,519 (0%) | 0% | - | Common Stock, par value $0.01 per share | |
| Lexeo Therapeutics Inc | Jenny R. Robertson | Chief Legal and Admin Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 23,750 | 23,750 | - | 0 | Common Stock | |
| Cloudflare Inc (Class A) | Prince Matthew | Director, CEO & Chair of the Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 79.39 per share. | 05 Jan 2024 | 23,675 | 0 (0%) | 0% | 79.4 | 1,879,497 | Class A Common Stock |
| EyePoint Pharma Inc | A. Goran Ando | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 23,598 | 23,598 | - | - | Stock Option (Right to Buy) | |
| LXP Industrial Trust | Nabil Andrawis | EVP, Director of Taxation | Grant, award, or other acquisition of securities at price $ 9.61 per share. | 05 Jan 2024 | 23,101 | 216,447 (0%) | 0% | 9.6 | 222,001 | Common Shares |
| EyePoint Pharma Inc | S. Nancy Lurker | Director, Executive Vice Chair | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.40 per share. | 05 Jan 2024 | 23,043 | 170,441 (0%) | 0% | 20.4 | 470,077 | Common Stock |
| Cloudflare Inc (Class A) | Prince Matthew | Director, CEO & Chair of the Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 78.50 per share. | 05 Jan 2024 | 22,984 | 23,675 (0%) | 0% | 78.5 | 1,804,219 | Class A Common Stock |
| Standard BioTools Inc | Eli D. Casdin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 22,866 | 22,866 | - | - | Stock Option (Right to buy) | |
| Standard BioTools Inc | Troy M. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 22,866 | 22,866 | - | - | Stock Option (Right to buy) | |
| Standard BioTools Inc | Casdin Eli D. | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 22,866 | 22,866 | - | - | Stock Option (Right to buy) | |
| Presidio Property Trust Inc (Class A) | Hightower Steven | Director, President, NetREIT Advisors | Grant, award, or other acquisition of securities at price $ 1.20 per share. | 05 Jan 2024 | 22,010 | 75,765 | - | 1.2 | 26,412 | Common Stock - Series A |
| Amplify Energy Corp | Willsher Martyn | Director, PRESIDENT, CEO | 05 Jan 2024 | 21,879 | 150,451 (0%) | 0% | 5.9 | 129,742 | Common Stock, par value $0.01 per share | |
| Global Partners LP - Unit | Slifka Eric | Director, Vice Chairman, President & CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 21,459 | 906,190 (2%) | 0% | 0 | Common units representing limited partner interests | |
| Global Partners LP - Unit | Eric Slifka | Director, Vice Chairman, President & CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 21,459 | 42,918 | - | - | Phantom Units | |
| EyePoint Pharma Inc | Jones David Scott | SVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 21,000 | 21,000 | - | - | Restricted Stock Units | |
| EyePoint Pharma Inc | A. Dario Paggiarino | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 21,000 | 21,000 | - | - | Restricted Stock Units | |
| EyePoint Pharma Inc | C. Michael Pine | Chief Corp Dev.&Strat. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 21,000 | 21,000 | - | - | Restricted Stock Units | |
| Teradata Corp | Todd Cione | Chief Revenue Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.49 per share. | 05 Jan 2024 | 20,954 | 105,472 (0%) | 0% | 42.5 | 890,335 | Common Stock |
| Presidio Property Trust Inc (Class A) | Durfey James | Director | Grant, award, or other acquisition of securities at price $ 1.20 per share. | 05 Jan 2024 | 20,920 | 113,444 | - | 1.2 | 25,104 | Common Stock - Series A |
| Presidio Property Trust Inc (Class A) | A. Jennifer Barnes | Director | Grant, award, or other acquisition of securities at price $ 1.20 per share. | 05 Jan 2024 | 20,920 | 84,326 | - | 1.2 | 25,104 | Common Stock - Series A |
| Presidio Property Trust Inc (Class A) | Hager Tracie | Director | Grant, award, or other acquisition of securities at price $ 1.20 per share. | 05 Jan 2024 | 20,920 | 43,321 | - | 1.2 | 25,104 | Common Stock - Series A |
| EyePoint Pharma Inc | S. Duker Jay | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 20,793 | 41,587 | - | - | Restricted Stock Units | |
| EyePoint Pharma Inc | Duker Jay S. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 20,793 | 50,014 (0%) | 0% | 0 | Common Stock | |
| Teradata Corp | Cione Todd | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 43.31 per share. | 05 Jan 2024 | 20,374 | 85,098 (0%) | 0% | 43.3 | 882,357 | Common Stock |
| Guggenheim Strategic Opportunities Fund | Barnes Randall | Director, TRUSTEE | Sale of securities on an exchange or to another person at price $ 13.60 per share. | 05 Jan 2024 | 20,000 | 15,849 (0%) | 0% | 13.6 | 272,000 | Common Stock |
| Backblaze Inc (Class A) | Cessna Tina | Senior VP, Engineering | 05 Jan 2024 | 20,000 | 122,250 | - | 7.0 | 140,600 | Class A Common Stock | |
| Backblaze Inc (Class A) | Tina Cessna | Senior VP, Engineering | 05 Jan 2024 | 20,000 | 122,250 | - | 7.1 | 141,000 | Class A Common Stock | |
| Backblaze Inc (Class A) | Tina Cessna | Senior VP, Engineering | 05 Jan 2024 | 20,000 | 85,279 | - | - | Stock Option (right to buy) | ||
| Backblaze Inc (Class A) | Tina Cessna | Senior VP, Engineering | 05 Jan 2024 | 20,000 | 142,250 | - | 2.5 | 50,800 | Class A Common Stock | |
| Backblaze Inc (Class A) | Cessna Tina | Senior VP, Engineering | 05 Jan 2024 | 20,000 | 65,279 | - | - | Stock Option (right to buy) | ||
| Backblaze Inc (Class A) | Cessna Tina | Senior VP, Engineering | 05 Jan 2024 | 20,000 | 142,250 | - | 2.5 | 50,800 | Class A Common Stock | |
| EyePoint Pharma Inc | John B. Landis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| APA | J. Stephen Riney | Executive Vice Pres & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 19,654 | 26,201 (0%) | 0% | 0 | Common Stock | |
| APA | J. Stephen Riney | Executive Vice Pres & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 19,654 | 54,749 | - | - | Restricted Stock / Units | |
| LXP Industrial Trust | Mark Cherone | SVP & Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 9.61 per share. | 05 Jan 2024 | 19,260 | 67,880 (0%) | 0% | 9.6 | 185,089 | Common Shares |
| APA | A. Pursell David | Exec. Vice Pres - Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 19,211 | 57,053 | - | - | Restricted Stock / Units | |
| APA | Clay D. Bretches | Exec. VP, Operations | 05 Jan 2024 | 19,211 | 57,053 | - | - | Restricted Stock / Units | ||
| Orthofix Medical Inc | Kimberley Elting A. | President, Global Orthopedics | Grant, award, or other acquisition of securities at price $ 13.29 per share. | 05 Jan 2024 | 18,811 | 238,998 (1%) | 0% | 13.3 | 249,998 | Common Stock |
| Amplify Energy Corp | Eric M. Willis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 18,643 | 65,520 | - | - | Performance Stock Units | |
| Zymeworks BC Inc | Galbraith Kenneth | Director, Chair & CEO | Sale of securities on an exchange or to another person at price $ 10.65 per share. | 05 Jan 2024 | 18,198 | 29,468 (0%) | 0% | 10.7 | 193,849 | Common Stock |
| APA | John Christmann J. | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.34 per share. | 05 Jan 2024 | 18,085 | 565,420 (0%) | 0% | 34.3 | 621,039 | Common Stock |
| Sabra Healthcare REIT Inc | Nevo-Hacohen Talya | Executive VP, CIO & Treasurer | 05 Jan 2024 | 17,684 | 223,614 (0%) | 0% | 13.6 | 241,210 | Common Stock | |
| Essential Properties Realty Trust Inc | M. Mavoides Peter | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.50 per share. | 05 Jan 2024 | 17,618 | 420,000 (0%) | 0% | 25.5 | 449,259 | Common Stock |
| Agios Pharma Inc | Fouse Jacqualyn A. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 17,500 | 124,466 (0%) | 0% | 0 | Common stock | |
| Agios Pharma Inc | A. Fouse Jacqualyn | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 17,500 | 0 | - | - | Performance share units | |
| TG Therapeutics Inc | N. Charney Laurence | Director | Sale of securities on an exchange or to another person at price $ 19.03 per share. | 05 Jan 2024 | 17,500 | 237,229 (0%) | 0% | 19.0 | 333,025 | Common Stock |
| Denali Therapeutics Inc | J. Watts Ryan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 19.43 per share. | 05 Jan 2024 | 17,483 | 2,276,181 (2%) | 0% | 19.4 | 339,695 | Common Stock |
| Backblaze Inc (Class A) | Cessna Tina | Senior VP, Engineering | 05 Jan 2024 | 17,279 | 139,529 | - | 2.5 | 43,889 | Class A Common Stock | |
| Backblaze Inc (Class A) | Cessna Tina | Senior VP, Engineering | 05 Jan 2024 | 17,279 | 48,000 | - | - | Stock Option (right to buy) | ||
| Backblaze Inc (Class A) | Tina Cessna | Senior VP, Engineering | 05 Jan 2024 | 17,279 | 122,250 | - | 7.3 | 125,618 | Class A Common Stock | |
| Zymeworks BC Inc | Andrew Moore Paul | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 17,166 | 17,166 (0%) | 0% | 0 | Common Stock | |
| Zymeworks BC Inc | Moore Paul Andrew | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 17,166 | 34,334 | - | - | Restricted Stock Unit | |
| SI-BONE Inc | Recupero J. Anthony | President, Commercial Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 17,002 | 266,912 (1%) | 0% | 0 | Common Stock | |
| SI-BONE Inc | Maheshwari Anshul | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 17,002 | 215,277 (0%) | 0% | 0 | Common Stock | |
| Opko Health Inc | Zerhouni A. Elias | Director, Vice Chairman and President | Purchase of securities on an exchange or from another person at price $ 0.87 per share. | 05 Jan 2024 | 17,000 | 19,794,514 (2%) | 0% | 0.9 | 14,790 | Common Stock |
| Credo Tech Grp Holding Ltd | Brennan William | Director, Pres & Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.53 per share. | 05 Jan 2024 | 16,531 | 440,577 | - | 17.5 | 289,788 | Ordinary Shares |
| Edgewell Personal Care Co | N. Hill John | Chief Human Resources Officer | Other type of transaction at price $ 0.00 per share. | 05 Jan 2024 | 16,353 | 0 | - | - | Performance Restricted Stock Equivalents (PRSE) 11/11/2022 | |
| TripAdvisor Inc | Goldberg Matt | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 16,116 | 62,042 (0%) | 0% | 0 | Common Stock | |
| TripAdvisor Inc | Matt Goldberg | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 16,116 | 161,157 | - | - | Restricted Stock Units | |
| Genie Energy Ltd (Class B) | Howard S. Jonas | Director, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.91 per share. | 05 Jan 2024 | 15,792 | 1,060,244 (4%) | 0% | 28.9 | 456,468 | Class B Common Stock, par value $.01 per share |
| Everspin Tech Inc | Sanjeev Aggarwal | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 05 Jan 2024 | 15,588 | 188,168 (1%) | 0% | 9 | 140,292 | Common Stock |
| Exelixis Inc | Eckhardt Sue Gail | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 15,424 | 15,424 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Mary C. Beckerle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 15,424 | 15,424 (0%) | 0% | 0 | Common Stock | |
| Cloudflare Inc (Class A) | Prince Matthew | Director, CEO & Chair of the Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 80.57 per share. | 05 Jan 2024 | 15,306 | 30,278 (0%) | 0% | 80.6 | 1,233,211 | Class A Common Stock |
| EyePoint Pharma Inc | Pine C. Michael | Chief Corp Dev.&Strat. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 15,285 | 30,570 | - | - | Restricted Stock Units | |
| EyePoint Pharma Inc | George Elston O. | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 15,285 | 30,570 | - | - | Restricted Stock Units | |
| EyePoint Pharma Inc | Dario A. Paggiarino | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 15,285 | 30,570 | - | - | Restricted Stock Units | |
| EyePoint Pharma Inc | Scott Jones David | SVP & Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 15,285 | 30,570 | - | - | Restricted Stock Units | |
| EyePoint Pharma Inc | C. Michael Pine | Chief Corp Dev.&Strat. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 15,285 | 19,628 (0%) | 0% | 0 | Common Stock | |
| EyePoint Pharma Inc | A. Dario Paggiarino | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 15,285 | 40,992 (0%) | 0% | 0 | Common Stock | |
| EyePoint Pharma Inc | Jones David Scott | SVP & Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 15,285 | 42,109 (0%) | 0% | 0 | Common Stock | |
| EyePoint Pharma Inc | George O. Elston | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 15,285 | 40,219 (0%) | 0% | 0 | Common Stock | |
| Edgewell Personal Care Co | Hill John N. | Chief Human Resources Officer | Other type of transaction at price $ 0.00 per share. | 05 Jan 2024 | 15,016 | 0 | - | - | Performance Restricted Stock Equivalents (PRSE) 11/12/2021 | |
| CSP Inc | Gary Southwell | VP and GM | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 15,000 | 50,051 (1%) | 0% | 0 | Common Stock | |
| Research Soln Inc | Victor Peter Derycz | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.71 per share. | 05 Jan 2024 | 15,000 | 3,170,884 | - | 2.7 | 40,650 | Common Stock |
| Ecovyst Inc | Feehan Michael | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.46 per share. | 05 Jan 2024 | 14,843 | 326,097 (0%) | 0% | 9.5 | 140,415 | Common Stock |
| APA | Lannie Anthony P. | Exec. Vice Pres & Gen Counsel | 05 Jan 2024 | 14,835 | 45,138 | - | - | Restricted Stock / Units | ||
| Intuit | A. Laura Fennell | EVP, People and Places | 05 Jan 2024 | 14,772 | 0 | - | - | Non-Qualified Stock Options (right to buy) | ||
| Intuit | A. Fennell Laura | EVP, People and Places | 05 Jan 2024 | 14,772 | 64,801 (0%) | 0% | 216.6 | 3,200,206 | Common Stock | |
| Intuit | A. Laura Fennell | EVP, People and Places | 05 Jan 2024 | 14,771 | 64,800 (0%) | 0% | 216.6 | 3,199,989 | Common Stock | |
| Intuit | Laura Fennell A. | EVP, People and Places | 05 Jan 2024 | 14,771 | 14,772 | - | - | Non-Qualified Stock Options (right to buy) | ||
| NB Bancorp Inc | Paul A. Evangelista | EVP, Dir Spec. Bank. Ctr. | Purchase of securities on an exchange or from another person at price $ 13.60 per share. | 05 Jan 2024 | 14,700 | 15,066 | - | 13.6 | 199,920 | Common Stock |
| APA | Maddox D Mark | Executive VP - Administration | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 14,453 | 39,341 | - | - | Restricted Stock / Units | |
| Amplify Energy Corp | Lopez Anthony William | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 14,382 | 45,213 | - | - | Performance Stock Units | |
| Coeptis Therapeutics Holdings Inc | David Mehalick | Director, CEO and President, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.66 per share. | 05 Jan 2024 | 14,004 | 2,782,615 | - | 0.7 | 9,243 | Common Stock |
| Amplify Energy Corp | Eric M. Willis | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.93 per share. | 05 Jan 2024 | 13,734 | 135,137 (0%) | 0% | 5.9 | 81,443 | Common Stock, par value $0.01 per share |
| APA | David A. Pursell | Exec. Vice Pres - Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 13,350 | 92,875 (0%) | 0% | 0 | Common Stock | |
| APA | David Pursell A. | Exec. Vice Pres - Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 13,350 | 37,842 | - | - | Restricted Stock / Units | |
| FiscalNote Holdings Inc (Class A) | Richard Henderson | Chief Revenue Officer | 05 Jan 2024 | 13,332 | 94,168 | - | 1.1 | 14,372 | Class A Common Stock | |
| APA | Riney J. Stephen | Executive Vice Pres & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 13,103 | 19,650 (0%) | 0% | - | Common Stock | |
| APA | Riney Stephen J. | Executive Vice Pres & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 13,103 | 74,403 | - | - | Restricted Stock / Units | |
| APA | Riney Stephen J. | Executive Vice Pres & CFO | Sale or transfer of securities back to the company at price $ 34.34 per share. | 05 Jan 2024 | 13,103 | 6,547 (0%) | 0% | 34.3 | 449,957 | Common Stock |
| F.N.B. Corp | Vincent Delie J. | Director, Chairman, President, & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.66 per share. | 05 Jan 2024 | 13,090 | 1,456,739 (0%) | 0% | 13.7 | 178,809 | Common Stock |
| Opko Health Inc | Pfenniger Richard C. | Director | Purchase of securities on an exchange or from another person at price $ 0.93 per share. | 05 Jan 2024 | 13,000 | 313,000 (0%) | 0% | 0.9 | 12,043 | Common Stock |
| APA | D. Bretches Clay | Exec. VP, Operations | 05 Jan 2024 | 12,807 | 69,860 | - | - | Restricted Stock / Units | ||
| APA | David A. Pursell | Exec. Vice Pres - Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 12,807 | 69,860 | - | - | Restricted Stock / Units | |
| Priority Technology Holdings | Kumar Rajiv | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 12,500 | 20,575 (0%) | 0% | - | Common Stock | |
| Priority Technology Holdings | Rajiv Kumar | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 12,500 | 50,000 | - | - | Restricted Stock Unit | |
| APA | Lannie P. Anthony | Exec. Vice Pres & Gen Counsel | 05 Jan 2024 | 12,371 | 91,683 (0%) | 0% | 0 | Common Stock | ||
| APA | P. Lannie Anthony | Exec. Vice Pres & Gen Counsel | 05 Jan 2024 | 12,371 | 30,303 | - | - | Restricted Stock / Units | ||
| ATI Inc | Elliot Davis | Chief Legal & Compl. Officer | Sale of securities on an exchange or to another person at price $ 43.37 per share. | 05 Jan 2024 | 12,123 | 123,926 (0%) | 0% | 43.4 | 525,775 | Common Stock, par value $0.10 per share |
| Agios Pharma Inc | Goff Brian | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 22.99 per share. | 05 Jan 2024 | 12,066 | 40,053 (0%) | 0% | 23.0 | 277,397 | Common stock |
| Opko Health Inc | Richard Pfenniger C. | Director | Purchase of securities on an exchange or from another person at price $ 0.95 per share. | 05 Jan 2024 | 12,000 | 325,000 (0%) | 0% | 0.9 | 11,386 | Common Stock |
| Meta | Mark Zuckerberg | Director, COB and CEO, Ten Percent Owner | 05 Jan 2024 | 11,976 | 11,976 (0%) | 0% | 0 | Class A Common Stock | ||
| Meta | Zuckerberg Mark | Director, COB and CEO, Ten Percent Owner | 05 Jan 2024 | 11,976 | 1,683,072 | - | - | Class B Common Stock | ||
| Coeptis Therapeutics Holdings Inc | Salkind Gene | Director | Purchase of securities on an exchange or from another person at price $ 0.69 per share. | 05 Jan 2024 | 11,600 | 284,056 | - | 0.7 | 8,004 | Common Stock |
| Workday (Class A) | David Duffield A. | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 264.75 per share. | 05 Jan 2024 | 11,053 | 157,468 (0%) | 0% | 264.7 | 2,926,230 | Class A Common Stock |
| Orthofix Medical Inc | Gillespie C. Geoffrey | VP, Controller, Interim CFO | 05 Jan 2024 | 10,967 | 10,967 | - | - | Employee Stock Option (Right to Buy) | ||
| Interactive Brokers Grp Inc (Class A) | Thomas A. Frank | Chief Information Officer | Sale of securities on an exchange or to another person at price $ 87.67 per share. | 05 Jan 2024 | 10,930 | 605,905 (0%) | 0% | 87.7 | 958,233 | Class A common stock |
| Coeptis Therapeutics Holdings Inc | Daniel Yerace | Director, VP of Operations | Purchase of securities on an exchange or from another person at price $ 0.69 per share. | 05 Jan 2024 | 10,850 | 1,071,455 | - | 0.7 | 7,487 | Common Stock |
| OneSpan Inc | Garg Sarika | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 10,823 | 29,124 (0%) | 0% | 0 | Common Stock | |
| OneSpan Inc | Michael J. McConnell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 10,823 | 68,849 (0%) | 0% | 0 | Common Stock | |
| OneSpan Inc | Michael J. McConnell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 10,823 | 0 | - | - | Restricted Stock Units | |
| OneSpan Inc | Johnson Marianne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 10,823 | 0 | - | - | Restricted Stock Units | |
| OneSpan Inc | Garry L. Capers | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 10,823 | 21,980 (0%) | 0% | 0 | Common Stock | |
| OneSpan Inc | Marc Boroditsky D. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 10,823 | 0 | - | - | Restricted Stock Units | |
| OneSpan Inc | Marc Boroditsky D. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 10,823 | 39,159 (0%) | 0% | 0 | Common Stock | |
| OneSpan Inc | Johnson Marianne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 10,823 | 31,500 (0%) | 0% | 0 | Common Stock | |
| OneSpan Inc | A. Nietzel Alfred | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 10,823 | 0 | - | - | Restricted Stock Units | |
| OneSpan Inc | Garry Capers L. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 10,823 | 0 | - | - | Restricted Stock Units | |
| OneSpan Inc | A. Alfred Nietzel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 10,823 | 43,274 (0%) | 0% | 0 | Common Stock | |
| OneSpan Inc | Garg Sarika | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 10,823 | 0 | - | - | Restricted Stock Units | |
| OneSpan Inc | Marc Zenner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 10,823 | 53,659 (0%) | 0% | 0 | Common Stock | |
| OneSpan Inc | Marc Zenner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 10,823 | 0 | - | - | Restricted Stock Units | |
| Crown Holdings Inc | J. Timothy Donahue | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Jan 2024 | 10,807 | 640,457 (0%) | 0% | 0 | Common | |
| Cloudflare Inc (Class A) | Matthew Prince | Director, CEO & Chair of the Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 77.31 per share. | 05 Jan 2024 | 10,514 | 0 (0%) | 0% | 77.3 | 812,857 | Class A Common Stock |
| Zymeworks BC Inc | Astle Christopher | SVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 10,500 | 12,497 (0%) | 0% | 0 | Common Stock | |
| Zymeworks BC Inc | Astle Christopher | SVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 10,500 | 21,000 | - | - | Restricted Stock Unit | |
| APA | Rebecca Hoyt A. | Sr. VP, Chief Acct Officer | 05 Jan 2024 | 10,352 | 30,262 | - | - | Restricted Stock / Units | ||
| Mission Produce Inc | J. Barnard Stephen | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.02 per share. | 05 Jan 2024 | 10,328 | 198,109 | - | 10.0 | 103,487 | COMMON STOCK |
| Mission Produce Inc | Juan Wiesner R. | Pres Central and South America | 05 Jan 2024 | 10,299 | 10,299 | - | 0 | COMMON STOCK | ||
| Amplify Energy Corp | Anthony William Lopez | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.93 per share. | 05 Jan 2024 | 10,244 | 77,275 (0%) | 0% | 5.9 | 60,747 | Common Stock, par value $0.01 per share |
| PTC Therapeutics Inc | Matthew B. Klein | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 27.15 per share. | 05 Jan 2024 | 10,107 | 168,155 (0%) | 0% | 27.1 | 274,393 | Common Stock |
| e.l.f. Beauty Inc | Scott Milsten K. | See remarks | Sale of securities on an exchange or to another person at price $ 150.06 per share. | 05 Jan 2024 | 10,000 | 79,104 (0%) | 0% | 150.1 | 1,500,633 | Common Stock, $0.01 par value |
| e.l.f. Beauty Inc | K. Milsten Scott | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 10,000 | 17,281 | - | - | Stock Option (Right to Buy) (Common Stock) | |
| e.l.f. Beauty Inc | Milsten Scott K. | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.00 per share. | 05 Jan 2024 | 10,000 | 89,104 (0%) | 0% | 17 | 170,000 | Common Stock, $0.01 par value |
| Toll Brothers Inc | E. Shapiro Paul | Director | Sale of securities on an exchange or to another person at price $ 99.70 per share. | 05 Jan 2024 | 10,000 | 119,704 (0%) | 0% | 99.7 | 997,028 | Common Stock |
| EyePoint Pharma Inc | Landis John B. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 10,000 | 10,000 | - | - | Restricted Stock Units | |
| Kingstone Cos. Inc | Chen Sarah | Chief Actuary and Senior VP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 10,000 | 10,000 | - | - | Stock Option | |
| Kingstone Cos. Inc | Gravelle L. Jennifer | Chief Financial Officer | 05 Jan 2024 | 10,000 | 10,000 | - | - | Stock Option | ||
| Opko Health Inc | D. Steven Rubin | Director, Executive VP-Administration | Purchase of securities on an exchange or from another person at price $ 0.87 per share. | 05 Jan 2024 | 10,000 | 6,187,732 (0%) | 0% | 0.9 | 8,669 | Common Stock |
| Scienture Holdings Inc | Surendra K. Ajjarapu | Director, Chairman and CEO | 05 Jan 2024 | 10,000 | 82,643 | - | 0 | Common Stock | ||
| Scienture Holdings Inc | Prashant Patel | Director, Interim CFO and Director | 05 Jan 2024 | 10,000 | 112,242 | - | 0 | Common Stock | ||
| Denali Therapeutics Inc | Ho Carole | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 19.43 per share. | 05 Jan 2024 | 9,972 | 198,777 (0%) | 0% | 19.4 | 193,756 | Common Stock |
| Denali Therapeutics Inc | O. Schuth Alexander | COFO and Secretary | Sale of securities on an exchange or to another person at price $ 19.43 per share. | 05 Jan 2024 | 9,972 | 539,307 (0%) | 0% | 19.4 | 193,756 | Common Stock |
| APA | Lannie P. Anthony | Exec. Vice Pres & Gen Counsel | 05 Jan 2024 | 9,890 | 55,028 | - | - | Restricted Stock / Units | ||
| V2X Inc | Beard William Wayne | SVP, Aerospace Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.96 per share. | 05 Jan 2024 | 9,768 | 54,701 (0%) | 0% | 42.0 | 409,865 | V2X, Inc. Common Stock |
| Workday (Class A) | A. Duffield David | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 266.58 per share. | 05 Jan 2024 | 9,648 | 105,297 (0%) | 0% | 266.6 | 2,571,932 | Class A Common Stock |
| APA | D Maddox Mark | Executive VP - Administration | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 9,635 | 48,976 | - | - | Restricted Stock / Units | |
| Research Soln Inc | Derycz Peter Victor | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.63 per share. | 05 Jan 2024 | 9,524 | 3,185,884 | - | 2.6 | 25,048 | Common Stock |
| SEMrush Holdings Inc (Class A) | Levin Eugenie | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 9,515 | 90,057 | - | - | Employee Stock Option (Right to Buy) | |
| SEMrush Holdings Inc (Class A) | Levin Eugenie | President | 05 Jan 2024 | 9,515 | 1,210,800 | - | - | Class B Common Stock | ||
| SEMrush Holdings Inc (Class A) | Eugenie Levin | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 9,515 | 1,220,315 | - | - | Class B Common Stock | |
| SEMrush Holdings Inc (Class A) | Levin Eugenie | President | Sale of securities on an exchange or to another person at price $ 12.52 per share. | 05 Jan 2024 | 9,515 | 302,691 | - | 12.5 | 119,128 | Class A Common Stock |
| SEMrush Holdings Inc (Class A) | Eugenie Levin | President | 05 Jan 2024 | 9,515 | 280,800 | - | 0 | Class A Common Stock | ||
| Credo Tech Grp Holding Ltd | Lam Yat Tung | Director, Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.53 per share. | 05 Jan 2024 | 9,414 | 3,098,198 | - | 17.5 | 165,027 | Ordinary Shares |
| Standard BioTools Inc | Michael Egholm | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 9,006 | 225,518 (0%) | 0% | 0 | Common Stock | |
| APA | A. Pursell David | Exec. Vice Pres - Development | Sale or transfer of securities back to the company at price $ 34.34 per share. | 05 Jan 2024 | 8,900 | 79,525 (0%) | 0% | 34.3 | 305,626 | Common Stock |
| APA | David Pursell A. | Exec. Vice Pres - Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 8,900 | 51,192 | - | - | Restricted Stock / Units | |
| APA | Pursell A. David | Exec. Vice Pres - Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 8,900 | 88,425 (0%) | 0% | - | Common Stock | |
| Teradata Corp | Todd Cione | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 43.31 per share. | 05 Jan 2024 | 8,877 | 76,221 (0%) | 0% | 43.3 | 384,454 | Common Stock |
| Halliburton | Miller A. Jeffrey | Director, Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.57 per share. | 05 Jan 2024 | 8,828 | 759,015 (0%) | 0% | 36.6 | 322,840 | Common Stock |
| Global Partners LP - Unit | Eric Slifka | Director, Vice Chairman, President & CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.00 per share. | 05 Jan 2024 | 8,673 | 897,517 (2%) | 0% | 42 | 364,266 | Common units representing limited partner interests |
| Citizens Inc (Class A) | Sheryl Kinlaw | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 8,535 | 31,856 (0%) | 0% | - | Citizens, Inc. Class A Common Stock | |
| Citizens Inc (Class A) | Sheryl Kinlaw | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 8,535 | 17,071 | - | - | Restricted Stock Units | |
| CSP Inc | Newbanks Michael | VP Finance and CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 8,500 | 50,307 (1%) | 0% | 0 | Common Stock | |
| CSP Inc | Levine W. Gary | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 8,500 | 98,942 (2%) | 0% | 0 | Common Stock | |
| Agios Pharma Inc | A. Fouse Jacqualyn | Director | Sale of securities on an exchange or to another person at price $ 22.99 per share. | 05 Jan 2024 | 8,391 | 116,075 (0%) | 0% | 23.0 | 192,909 | Common stock |
| APA | Clay Bretches D. | Exec. VP, Operations | 05 Jan 2024 | 8,344 | 44,236 (0%) | 0% | 34.3 | 286,533 | Common Stock | |
| APA | Clay D. Bretches | Exec. VP, Operations | 05 Jan 2024 | 8,344 | 46,186 | - | - | Restricted Stock / Units | ||
| APA | Bretches D. Clay | Exec. VP, Operations | 05 Jan 2024 | 8,344 | 52,580 (0%) | 0% | 0 | Common Stock | ||
| APA | Bretches D. Clay | Exec. VP, Operations | 05 Jan 2024 | 8,344 | 52,580 (0%) | 0% | - | Common Stock | ||
| APA | D. Bretches Clay | Exec. VP, Operations | 05 Jan 2024 | 8,344 | 37,842 | - | - | Restricted Stock / Units | ||
| Priority Technology Holdings | Rajiv Kumar | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 8,334 | 28,909 (0%) | 0% | - | Common Stock | |
| Priority Technology Holdings | Kumar Rajiv | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 8,334 | 16,666 | - | - | Restricted Stock Unit | |
| APA | P. Anthony Lannie | Exec. Vice Pres & Gen Counsel | 05 Jan 2024 | 8,247 | 42,674 | - | - | Restricted Stock / Units | ||
| APA | Lannie P. Anthony | Exec. Vice Pres & Gen Counsel | 05 Jan 2024 | 8,247 | 87,559 (0%) | 0% | - | Common Stock | ||
| APA | P. Anthony Lannie | Exec. Vice Pres & Gen Counsel | 05 Jan 2024 | 8,247 | 79,312 (0%) | 0% | 34.3 | 283,202 | Common Stock | |
| Intuit | A. Laura Fennell | EVP, People and Places | 05 Jan 2024 | 8,228 | 50,029 (0%) | 0% | 600.2 | 4,938,432 | Common Stock | |
| Thryv Holdings Inc | Bolger Lesley | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.23 per share. | 05 Jan 2024 | 7,982 | 45,780 | - | 18.2 | 145,512 | Common Stock |
| Thryv Holdings Inc | John Wholey F. | Executive VP of Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.23 per share. | 05 Jan 2024 | 7,982 | 146,393 | - | 18.2 | 145,512 | Common Stock |
| Thryv Holdings Inc | John F. Wholey | Executive VP of Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.23 per share. | 05 Jan 2024 | 7,982 | 145,078 | - | 18.2 | 145,512 | Common Stock |
| APA | D Mark Maddox | Executive VP - Administration | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 7,961 | 24,888 | - | - | Restricted Stock / Units | |
| APA | Maddox Mark D | Executive VP - Administration | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 7,961 | 61,112 (0%) | 0% | 0 | Common Stock | |
| Global Partners LP - Unit | A. Romaine Mark | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 7,868 | 15,737 | - | - | Phantom Units | |
| Global Partners LP - Unit | A. Romaine Mark | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 7,868 | 110,962 (0%) | 0% | 0 | Common units representing limited partner interests | |
| Intuit | Fennell Laura A. | EVP, People and Places | 05 Jan 2024 | 7,817 | 51,029 (0%) | 0% | 590.6 | 4,616,811 | Common Stock | |
| AutoZone | Thomas Newbern B. | COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 772.80 per share. | 05 Jan 2024 | 7,800 | 10,319 (0%) | 0% | 772.8 | 6,027,840 | Common Stock |
| AutoZone | Newbern B. Thomas | COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 7,800 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| APA | J. Riney Stephen | Executive Vice Pres & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.34 per share. | 05 Jan 2024 | 7,734 | 18,467 (0%) | 0% | 34.3 | 265,586 | Common Stock |
| LXP Industrial Trust | Andrawis Nabil | EVP, Director of Taxation | Grant, award, or other acquisition of securities at price $ 9.61 per share. | 05 Jan 2024 | 7,710 | 193,346 (0%) | 0% | 9.6 | 74,093 | Common Shares |
| Thryv Holdings Inc | McCusker James | Chief Revenue Officer and EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.23 per share. | 05 Jan 2024 | 7,558 | 58,309 | - | 18.2 | 137,782 | Common Shares |
| Crown Holdings Inc | J. Donahue Timothy | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 90.96 per share. | 05 Jan 2024 | 7,500 | 651,264 (0%) | 0% | 91.0 | 682,200 | Common |
| Lulus Fashion Lounge Holdings Inc | Sheu S. Caroline | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 7,487 | 134,815 | - | 0 | Common Stock | |
| Zymeworks BC Inc | Andrew Paul Moore | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 10.65 per share. | 05 Jan 2024 | 7,460 | 9,706 (0%) | 0% | 10.7 | 79,465 | Common Stock |
| APA | D. Clay Bretches | Exec. VP, Operations | 05 Jan 2024 | 7,403 | 54,530 | - | - | Restricted Stock / Units | ||
| APA | Clay D. Bretches | Exec. VP, Operations | 05 Jan 2024 | 7,403 | 51,639 (0%) | 0% | - | Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.